Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine posterior spinal nerve block for analgesia in percutaneous vertebroplasty
ChiCTR2500115064Phase 4Completed
- Sponsor
- Chengdu First Orthopedic Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in vertebral compression fracture (VCF) (3 arms), sponsored by Chengdu First Orthopedic Hospital. Primary endpoints: Postoperative VAS pain score and Opioid drug consumption during surgery. Started Dec 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
vertebral compression fracture (VCF)
Beyond the preview
Go deeper on ChiCTR2500115064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115064.